留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x

微循环障碍与急性心肌梗死患者梗死面积、心肌应变及临床预后的相关性分析

丁丝雨 丁斌 宋禧龙 李尧 牛奇林 宋宏伟 宣玲 史晓俊 高大胜 王洪巨 李妙男

丁丝雨, 丁斌, 宋禧龙, 李尧, 牛奇林, 宋宏伟, 宣玲, 史晓俊, 高大胜, 王洪巨, 李妙男. 微循环障碍与急性心肌梗死患者梗死面积、心肌应变及临床预后的相关性分析[J]. 分子影像学杂志, 2023, 46(6): 1001-1008. doi: 10.12122/j.issn.1674-4500.2023.06.08
引用本文: 丁丝雨, 丁斌, 宋禧龙, 李尧, 牛奇林, 宋宏伟, 宣玲, 史晓俊, 高大胜, 王洪巨, 李妙男. 微循环障碍与急性心肌梗死患者梗死面积、心肌应变及临床预后的相关性分析[J]. 分子影像学杂志, 2023, 46(6): 1001-1008. doi: 10.12122/j.issn.1674-4500.2023.06.08
DING Siyu, DING Bin, SONG Xilong, LI Yao, NIU Qilin, SONG Hongwei, XUAN Ling, SHI Xiaojun, GAO Dasheng, WANG Hongju, LI Miaonan. Correlation analysis of microcirculation disorders with infarct size, myocardial strain, and clinical prognosis in patients with acute myocardial infarction[J]. Journal of Molecular Imaging, 2023, 46(6): 1001-1008. doi: 10.12122/j.issn.1674-4500.2023.06.08
Citation: DING Siyu, DING Bin, SONG Xilong, LI Yao, NIU Qilin, SONG Hongwei, XUAN Ling, SHI Xiaojun, GAO Dasheng, WANG Hongju, LI Miaonan. Correlation analysis of microcirculation disorders with infarct size, myocardial strain, and clinical prognosis in patients with acute myocardial infarction[J]. Journal of Molecular Imaging, 2023, 46(6): 1001-1008. doi: 10.12122/j.issn.1674-4500.2023.06.08

微循环障碍与急性心肌梗死患者梗死面积、心肌应变及临床预后的相关性分析

doi: 10.12122/j.issn.1674-4500.2023.06.08
基金项目: 

国家自然科学基金 81970313

安徽省临床医学研究转化专项 202304295107020086

安徽省教育厅自然科学研究重点项目 2022AH051477

蚌埠医学院第一附属医院2022年度高新技术 2022050

蚌埠医学院512人才培育计划 by51201317

蚌埠医学院512人才培育计划 by51201105

安徽省高校重点研究项目 SK2021A0433

详细信息
    作者简介:

    丁丝雨,在读硕士研究生,住院医师,E-mail: 1966653522@qq.com

    通讯作者:

    李妙男,副主任医师,副教授,硕士生导师,E-mail: 524760484@qq.com

Correlation analysis of microcirculation disorders with infarct size, myocardial strain, and clinical prognosis in patients with acute myocardial infarction

Funds: 

National Natural Science Foundation of China 81970313

 202304295107020086

 2022AH051477

 2022050

 by51201317

 by51201105

 SK2021A0433

  • 摘要:   目的  分析心脏磁共振评估急性心肌梗死患者微循环障碍(MVO)与梗死面积、心肌应变及临床预后的相关性。  方法  选择2022年6~12月蚌埠医学院第一附属医院收治的24例因ST段抬高型心肌梗死(STEMI)行经皮冠状动脉介入治疗术治疗的患者为对象,其中男性22例,女性2例,年龄55.3±11.3岁。所有患者于术后5~7 d进行心脏磁共振检查,根据是否出现MVO,将24例患者分为MVO组(n=16)和非MVO组(n=8),比较两组基线资料、心功能、心肌梗死面积(LGE%)、心肌应变。对出院的STEMI患者进行平均6月的门诊或电话随访,记录心血管不良事件(MACEs)的发生情况,比较两组发生MACEs事件的差异。本研究定义的MACEs事件包括:再发胸痛、心力衰竭、脑卒中、再发心梗、出血、再次血运重建、支架内血栓、支架内再狭窄、死亡。  结果  MVO组梗死节段径向应变、梗死节段周向及整体周向应变功能均低于无MVO组(P < 0.05);MVO组心肌梗死面积大于无MVO组(25.18%±10.51% vs 9.93%±5.96%)。MVO组左心室射血分数与径向应变及周向应变呈极强相关关系[r=0.815 (0.536~0.934),P < 0.001;r=-0.938(-0.978~-0.852),P < 0.001],与纵向应变呈强相关关系[r=-0.767(-0.915~-0.437),P < 0.001]。二元回归分析中LGE%及梗死节段周向应变是STEMI患者发生MVO的独立危险因素。单因素分析ROC曲线显示,LGE%可以辅助于MVO的诊断,曲线下面积(AUC)为0.922(0.796~1.000),其最佳截断点为14.92%,敏感度为87.5%,特异性为87.5%(P < 0.05)。梗死节段周向应变对MVO也具有诊断价值,AUC为0.781(0.591~0.971),其最佳截断点为10.58%,敏感度为62.5%,特异性为87.5%(P < 0.05)。LGE%联合梗死节段周向应变后,其对MVO诊断的AUC及敏感度均上升,AUC为0.938(0.827~1.000),敏感度为93.8%,特异性为87.5%(P < 0.05)。随访所有STEMI患者,10例发生MACEs事件(41.7%),两组患者发生MACEs事件的差异无统计学意义(P=0.558)。  结论  LGE%、心肌梗死节段周向应变是STEMI患者经皮冠状动脉介入治疗术后出现MVO的独立危险因素,也分别对MVO具有较高的诊断价值,两者联合诊断MVO时诊断价值更高。径向应变、周向应变、纵向应变与MVO组左心室射血分数具有较强的相关性。

     

  • 图  1  男,49岁,急性下壁心肌梗死介入术后7 d行CMR检查,延迟强化中出现的低信号区(MVO)

    Figure  1.  A 49-year-old male patient with acute inferior myocardial infarction underwent CMR examination 7 d after interventional surgery, showing a low signal area (MVO) in delayed enhancement.

    图  2  男,55岁,急性下壁心肌梗死介入术后7 d行CMR检查

    Figure  2.  A 55- year- old male underwent CMR examination 7 d after interventional surgery for acute inferior myocardial infarction. A: The left ventricular myocardial radial strain decreased (normal value 30%-40%); B: The left ventricular myocardial circumferential strain decreased (normal value - 15%- 20%); C: The left ventricular myocardial longitudinal strain peakdecreased (normal value-15%-20%).

    图  3  周向应变、纵向应变、径向应变与射血分数线性关系

    Figure  3.  The linear relationship between RS, CS, LS and LVEF. A: The linear relationship between CS and LVEF; B: The linear relationship between LS and LVEF; C: The linear relationship between RS and LVEF.

    图  4  二元Logistic回归分析MVO的独立危险因素

    Figure  4.  Binary Logistic regression analysis of independent risk factors for MVO.

    图  5  LGE%及联合诊断对MVO诊断的ROC曲线

    Figure  5.  ROC curve of LGE% and combined diagnosis for MVO diagnosis.

    表  1  MVO组与非MVO组一般资料分析

    Table  1.   Analysis of general data of MVO group and non-MVO group

    Index MVO group (n=16) Non-MVO group (n=8) P
    Gender(Male/Female) 14/2 8/0 0.296
    Age(year) 57.31±12.41 51.25±7.25 0.223
    Diabetes 6(37.5) 2(25.0) 0.607
    Smoking 12(75.0) 6(75.0) 0.698
    G(mmol/L) 8.30(6.29, 12.10) 8.34(5.89, 9.78) 0.624
    UA (μmol/L) 291.00(249.15, 386.75) 377.00(304.00, 396.75) 0.270
    CR(μmol/L) 66.50(57.25, 90.25) 69.50(55.50, 82.00) 0.878
    LDL(mmol/L) 2.70(2.15, 2.92) 2.68(1.49, 3.85) 0.976
    HDL(mmol/L) 0.96(0.82, 1.12) 0.91(0.86, 1.01) 0.806
    TN-I(μg/L) 17.19(11.84, 29.73) 10.28(5.05, 19.75) 0.221
    CK-MB(U/L) 42.50(31.50, 114.50) 40.00(29.75, 125.50) 0.902
    G: Glucose; UA: Uric acid; CR: Creatinine; LDL: Low-density lipoprotein; HDL: High-density lipoprotein; TN-I: Troponin-I; CK-MB: Creatine kinase isoenzyme.
    下载: 导出CSV

    表  2  两组PCI术后结果相关信息分析

    Table  2.   Analysis of information related to the results after PCI between the two groups [n(%)]

    Index MVO group (n=16) Non-MVO group (n=8) P
    Nember of diseased branches
       Single vessel 2(12.50) 3(37.50) 0.053
       Two blood vessels 3(18.75) 2(25.00) 0.722
       Three blood vessels 11(68.75) 3(37.50) 0.074
    Criminal blood vessel
       LAD 8(50.00) 5(62.50) 0.562
       LCX 2(12.50) 0(00.00) 0.296
       RCA 6(37.50) 3(37.5) >0.999
       Gensini (Mean±SD) 128.19±58.46 101.25±60.38 0.304
    LAD: Left anterior descending artery; LCX: Left circumflex branch; RCA: Right coronary artery.
    下载: 导出CSV

    表  3  心功能及心肌梗死面积相关资料分析

    Table  3.   Analysis of data related to cardiac function and myocardial infarction area (Mean±SD)

    Index MVO group (n=16) Non-MVO group (n=8) P
    LVEDV/BSA(mL/m2) 75.05±21.18 68.01±10.32 0.387
    LVESV/BSA(mL/m2) 41.45±20.19 30.61±7.73 0.160
    LVEF(%) 45.81±16.21 55.50±5.93 0.119
    LGE(%) 25.18±10.51 9.93±5.96 <0.001
    LVEDV/BSA: Left ventricular end-diastolic volume/body surface area; LVESV/BSA: Left ventricular end-systolic volume/body surface area; LVEF: Left ventricular ejection fraction; LGE: Late gadolinium enhancement.
    下载: 导出CSV

    表  4  心肌强化节段心肌应变功能参数分析

    Table  4.   Analysis of myocardial strain function parameters in dead segment of myocardial infarction (%, Mean±SD)

    Functiongal parameters MVO group (n=16) Non-MVO group (n=8) P
    Radial strain in infarction stage 15.48±8.18 22.25±9.21 0.032
    Circumferential strain in infarction stage -10.86±3.48 -14.81±4.23 0.023
    Longitudinal strain in infarction stage -10.57±4.79 -11.61±1.52 0.438
    下载: 导出CSV

    表  5  心肌整体各方向应变比较

    Table  5.   Comparison of strain in all directions of myocardium (Mean±SD)

    Functiongal parameters MVO group (n=16) Non-MVO group (n=8) P
    Global radial strain 26.19±9.81 31.78±11.27 0.223
    Global circumferential strain -14.61±3.73 -17.86±3.14 0.046
    Overall longitudinal strain -11.49±4.87 -12.87±2.91 0.472
    下载: 导出CSV

    表  6  MVO联合诊断的曲线下面积

    Table  6.   Area under the curve for MVO joint diagnosis

    Project AUC P 95% CI
    LGE% 0.922 0.027 0.796-1.000
    Circumferential strain of infarct segments 0.781 0.001 0.591-0.971
    Joint diagnosis 0.938 0.001 0.827-1.000
    下载: 导出CSV
  • [1] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J]. 中华心血管病杂志, 2019, 47(10): 766-83. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJXB201709002.htm
    [2] Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2011, 32 (23): 2999-3054. doi: 10.1093/eurheartj/ehr236
    [3] van Kranenburg M, Magro M, Thiele H, et al. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients[J]. JACC, 2014, 7(9): 930-9.
    [4] de Waha S, Patel MR, Granger CB, et al. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials[J]. Eur Heart J, 2017, 38(47): 3502-10. doi: 10.1093/eurheartj/ehx414
    [5] 李璐, 赵世华. 磁共振成像识别急性心肌梗死后微循环障碍的研究进展[J]. 中华心血管病杂志, 2019, 47(4): 335-8. doi: 10.3760/cma.j.issn.0253-3758.2019.04.014
    [6] Galasko GI, Basu S, Lahiri A, et al. A prospective comparison of echocardiographic wall motion score index and radionuclide ejection fraction in predicting outcome following acute myocardial infarction[J]. Heart, 2001, 86(3): 271-6. doi: 10.1136/heart.86.3.271
    [7] Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J]. Eur Heart J, 2021, 42 (14): 1289-367. doi: 10.1093/eurheartj/ehaa575
    [8] Kramer CM, Barkhausen J, Bucciarelli-Ducci C, et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update[J]. J Cardiovasc Magn Reson, 2020, 22(1): 17. doi: 10.1186/s12968-020-00607-1
    [9] Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association[J]. Circulation, 2002, 105(4): 539-42. doi: 10.1161/hc0402.102975
    [10] Doherty DJ, Sykes R, Mangion K, et al. Predictors of microvascular reperfusion after myocardial infarction[J]. Curr Cardiol Rep, 2021, 23(3): 21. doi: 10.1007/s11886-021-01442-1
    [11] Christoph G, Stark Anselm W, Kady F, et al. Diagnostic performance of cardiac magnetic resonance segmental myocardial strain for detecting microvascular obstruction and late gadolinium enhancement in patients presenting after a ST-elevation myocardial infarction[J]. Front Cardiovasc Med, 2022, 9: 909204. doi: 10.3389/fcvm.2022.909204
    [12] Iwakura K, Ito H, Ikushima M, et al. Association between hyperglycemia and the no-reflow phenomenon inpatients with acute myocardial infarction[J]. J Am Coll Cardiol, 2003, 41(1): 1-7. doi: 10.1016/S0735-1097(02)02626-8
    [13] Resnic FS, Wainstein M, Lee MKY, et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention[J]. Am Heart J, 2003, 145(1): 42-6. doi: 10.1067/mhj.2003.36
    [14] Gick M, Jander N, Bestehorn HP, et al. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation[J]. Circulation, 2005, 112(10): 1462-9. doi: 10.1161/CIRCULATIONAHA.105.545178
    [15] Marc MC, Iancu AC, Bãlãnescu Ş, et al. Microvascular obstruction in acute myocardial infarction: an old and unsolved mystery[J]. Med Pharm Rep, 2019, 92(3): 216-9.
    [16] Song LS, Ma XH, Zhao XX, et al. Validation of black blood late gadolinium enhancement (LGE) for evaluation of myocardial infarction in patients with or without pathological Q-wave on electrocardiogram (ECG)[J]. Cardiovasc Diagn Ther, 2020, 10(2): 124-34. doi: 10.21037/cdt.2019.12.11
    [17] 蔡宜婷, 邢浩然, 郝明辉, 等. STEMI再灌注微血管损伤的心脏磁共振成像新进展[J]. 中华心血管病杂志, 2022, 50(12): 1237-42. doi: 10.3760/cma.j.cn112148-20220403-00240
    [18] Rigolli M, Anandabaskaran S, Christiansen JP, et al. Bias associated with left ventricular quantification by multimodality imaging: a systematic review and meta-analysis[J]. Open Heart, 2016, 3(1): e000388. doi: 10.1136/openhrt-2015-000388
    [19] Reant P, Barbot L, Touche C, et al. Evaluation of global left ventricular systolic function using three-dimensional echocardiography speckle-tracking strain parameters[J]. J Am Soc Echocardiogr, 2012, 25(1): 68-79. doi: 10.1016/j.echo.2011.10.009
    [20] Pierpaolo P, Rolf S, Manuel BP, et al. Left ventricular global myocardial strain assessment: are CMR feature-tracking algorithms useful in the clinical setting?[J]. La Radiol Med, 2020, 125(5): 444-50. doi: 10.1007/s11547-020-01159-1
    [21] Dobrovie M, Barreiro-Pérez M, Curione D, et al. Inter-vendor reproducibility and accuracy of segmental left ventricular strain measurements using CMR feature tracking[J]. Eur Radiol, 2019, 29(12): 6846-57. doi: 10.1007/s00330-019-06315-4
    [22] Li H, Qu YY, Metze P, et al. Quantification of biventricular myocardial strain using CMR feature tracking: reproducibility in small animals[J]. BioMed Res Int, 2021, 2021: 1-14.
    [23] Bergerot C, Mewton N, Lacote- Roiron C, et al. Influence of microvascular obstruction on regional myocardial deformation in the acute phase of myocardial infarction: a speckle-tracking echocardiography study[J]. J Am Soc Echocardiogr, 2014, 27(1): 93-100. doi: 10.1016/j.echo.2013.09.011
    [24] Bekkers SCAM, Smulders MW, Passos VL, et al. Clinical implications of microvascular obstruction and intramyocardial haemorrhage in acute myocardial infarction using cardiovascular magnetic resonance imaging[J]. Eur Radiol, 2010, 20(11): 2572-8. doi: 10.1007/s00330-010-1849-9
    [25] 侯洁, 肖俊睿, 孙玉, 等. 磁共振延迟强化对急性心肌梗死的诊断价值[J]. 中华心血管病杂志, 2018, 46(8): 635-9. doi: 10.3760/cma.j.issn.0253-3758.2018.08.011
    [26] Szummer K, Wallentin L, Lindhagen L, et al. Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence- based treatments: experiences from the SWEDEHEART registry 1995-2014 [J]. Eur Heart J, 2017, 38(41): 3056-65. doi: 10.1093/eurheartj/ehx515
    [27] Durante A, Camici PG. Response by durante and camici to letter regarding article, "identification of high-risk patients after STsegment elevation myocardial infarction: comparison between angiographic and magnetic resonance parameters"[J]. Circ, 2017, 10(9): e005841.
  • 加载中
图(5) / 表(6)
计量
  • 文章访问数:  70
  • HTML全文浏览量:  7
  • PDF下载量:  6
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-07-18
  • 网络出版日期:  2023-12-26
  • 刊出日期:  2023-11-20

目录

    /

    返回文章
    返回

    关于《分子影像学杂志》变更刊期通知

    各位专家、作者、读者:

    为了缩短出版时滞,促进科研成果的快速传播,我刊自2024年1月起,刊期由双月刊变更为月刊。本刊主要栏目有:基础研究、临床研究、技术方法、综述等。

    感谢各位专家、作者、读者长期以来对我刊的支持与厚爱!

    南方医科大学学报编辑部

    《分子影像学杂志》

    2023年12月27日